 | Up a level |
Journal Article
Berthold, F., Faldum, A., Ernst, A., Boos, J., Dilloo, D., Eggert, A., Fischer, M., Fruehwald, M., Henze, G., Klingebiel, T., Kratz, C., Kremens, B., Krug, B., Leuschner, I, Schmidt, M., Schmidt, R., Schumacher-Kuckelkorn, R., von Schweinitz, D., Schilling, F. H., Theissen, J., Volland, R., Hero, B. and Simon, T. (2020). Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR. Ann. Oncol., 31 (3). S. 422 - 430. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Nuchtern, J., Bagatelle, R., McHugh, K., Naranjo, A., Van Ryn, C., Rojas, Y., Lyons, K., Guillerman, P., Kirby, C., Brock, P., Volchenboum, S., Simon, T., States, L., Miller, A., Krug, B., Sarnaki, S., Valteau-Couannet, D., von Schweinitz, D., Kammer, B., Granata, C., Pio, L. and Park, J. (2015). A SUBSET OF IMAGE DEFINED RISK FACTORS PREDICTS COMPLETENESS OF RESECTION IN CHILDREN WITH HIGH-RISK NEUROBLASTOMA: AN INTERNATIONAL MULTICENTER STUDY. Pediatr. Blood Cancer, 62. S. S185 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1545-5017
Tulla, M., Berthold, F., Graf, N., Rutkowski, S., von Schweinitz, D., Spix, C. and Kaatsch, P. (2015). Incidence, Trends, and Survival of Children With Embryonal Tumors. Pediatrics, 136 (3). S. E623 - 10. ELK GROVE VILLAGE: AMER ACAD PEDIATRICS. ISSN 1098-4275